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Abstract
Literature on socioeconomic determinants of antibiotic consumption in the
community is limited to few countries using cross-sectional data. This paper
analyses regional variations in outpatient antibiotics in Italy using a balanced
panel dataset covering the period 2000-2008. We specify an econometric model
in which antibiotic consumption depends upon demographic and socioeconomic
characteristics of the population, the supply of health care services in the commu-
nity, and antibiotic copayments. The model is estimated by means of Ordinary
least squares techniques with xed e¤ects (FE). The implications of consumption
externalities across geographical areas are investigated by means of spatial-lag
and spatial-error models (SLFE and SEFE). We nd signicant and positive in-
come elasticity and negative e¤ects of copayments. Antibiotic use is also a¤ected
by the age structure of the population and the supply of community health care.
Finally, we nd evidence of spatial dependency in the use of antibiotics across
regions. This suggests that regional policies (e.g. public campaigns) aimed at
increasing e¢ ciency in antibiotic consumption and controlling bacterial resis-
tance may be inuenced by policy makers in neighbouring regions. There will
be scope for a strategic and coordinated view of regional policies towards the
use of antibiotics.
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1 Introduction
The increasing use of antibiotics and the consequent harmful e¤ects of bacterial re-
sistance represent a growing problem in many countries. Evidence suggests that
bacterial resistance grows with antibiotic use (Monroe and Polk, 2000; Mera et al.,
2006). Although the e¤ects of intervention policies on resistance to antimicrobial
drugs cannot be assessed accurately at present, public interventions may be e¤ective
in controlling antibiotic consumption (Huttner et al., 2010). Consequently, the in-
vestigation of socioeconomic inequalities in the use of antibiotics across geographic
areas is an important approach in understanding causes of consumption and building
e¤ective intervention policies.
Literature shows that outpatient antibiotic consumption, measured by the num-
ber of dened daily doses per 1000 inhabitants (DID), is highly heterogeneous across
European countries (Elseviers et al., 2007). For instance, the consumption of an-
timicrobials in France is almost three times the consumption in the Netherlands.
Generally, southern European countries exhibit higher levels of consumption as com-
pared to northern European countries.
Outpatient antibiotic consumption is also highly heterogeneous across geographic
areas within a country (Kern et al., 2006). To our knowledge, the study of socioe-
conomic determinants of consumption has been applied to few countries (Matuz et
al., 2005; Filippini et al., 2006; Nitzan et al., 2010). Since previous studies are based
on cross-sectional data, unobserved heterogeneity may stem from omitted common
variables that a¤ect geographic areas di¤erently. These latent common factors may
induce cross-section dependence and lead to inconsistent estimation coe¢ cients in re-
gressions if hidden aspects are correlated with the explanatory variables (see Cameron
and Trivedi, 2005).
Spatial econometric approaches to antibiotic consumption are lacking. Geo-
graphic areas are usually treated as isolated entities, ignoring the fact that antibiotic
consumption is plausibly a¤ected by consumption in neighbouring regions. Spatial
interactions in panel data are considered, for instance, by Revelli (2001) to investi-
gate variations in tax rates across English districts, and by Costa-Font and Moscone
(2008) to study health expenditure across Spanish regions. As for antibiotics, spatial
aspects are partially addressed in recent studies by Filippini et al. (2009a, 2009b)
using cross-sectional data. Spatial dependency plays an important role in the use
of antibiotics for two main reasons. First, antibiotics are used to cure infections
which may spread to other individuals in the community. Second, antimicrobial re-
sistance partially generated by the intensive use of antibiotics may reduce antibiotic
e¤ectiveness for other individuals in the community. It follows that regional policies
(e.g. public campaigns) aimed at increasing e¢ ciency in antibiotic consumption and
controlling bacterial resistance could blunt the impact of policies in neighbouring
regions through the generation of local spillovers. This may suggest that the lack of
coordination of regional policies towards the use of antibiotics leads to ine¢ ciency.
The purpose of this study is to investigate socioeconomic factors a¤ecting re-
gional variations in outpatient antibiotic use in Italy over a relatively large period of
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time (2000-2008), by means of panel data analysis which takes the external e¤ects of
consumption into account. The use of panel data makes it possible to specify xed
regional e¤ects in order to take the unobserved heterogeneity into account. A novelty
of our work is that it focuses on a country, Italy, of which socioeconomic determinants
of antibiotic use in outpatients have not been investigated so far. The relevance of
this focus also originates from the peculiar organization of the Italian health care
system, which is based upon a National Health Service where the provision of health
care is substantially devolved to regional health authorities. A question arises as
to whether the e¤ects of main socioeconomic determinants of consumption are sim-
ilar in countries with di¤erent health care organizations, since previous studies are
conducted in health care systems based upon health insurance plans.
According to a recent report of the European Commission (2010), Italy is the
most consuming country of antibiotics in Europe with relatively poor levels of pub-
lic awareness of antibiotic e¢ cacy. This suggests that the investigation of factors
a¤ecting the use of antibiotics may raise more concern compared to other countries.
Similarly to previous studies, our model hypothesises that regional consumption of
outpatient antibiotics in Italy depends on antibiotic price (copayments), population
age structure and income, the supply of health care services in the community, and
the health status of the population. The model is estimated by means of Ordinary
least squares with xed e¤ects (FE). Consumption externalities between regions are
investigated by means of spatial-lag and spatial-error models with xed e¤ects (SLFE
and SEFE). Spatial lags may reect interactions between regions whereas spatial er-
rors occur because regions have unobserved factors in common.
The remaining of the paper is organized as follows. Section 2 provides an overview
of the literature on socioeconomic determinants of antimicrobial use across geo-
graphic areas. In Section 3 we summarise the main features of the Italian market for
primary care and antibiotic use in outpatients. The specication of the economet-
ric model and the estimation approaches are presented in Section 4 and Section 5,
respectively. Section 6 discusses the results and Section 7 concludes.
2 A review on socioeconomic determinants of antibiotic
consumption
The literature on socioeconomic determinants of outpatient antibiotic consumption
is limited to few empirical studies, although there are more general studies on the
determinants of pharmaceuticals use (e.g. Costa-Font et al., 2007). We present ve
studies which investigate the impact of socioeconomic factors within countries.1 The
main features of these studies - geographical setting, type of data, methodological
approach, determinants cosidered and results - are summarised in Table 1.
1Regarding cross-country studies, we refer the reader to the recent analysis by Masiero et al.
(2010) using European data.
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Nitzan et al. (2010) analyse the use of antibiotics in outpatients in 8 districts
of Israel. The authors investigate consumption measured in dened daily doses per
1000 inhabitants for di¤erent age groups and for di¤erent groups of antibiotics. The
study shows a decline in antibiotic use in all districts between 2003 and 2005 and
large variation between districts. Results reveal that during the 3 years of the study
the highest antibiotic consumption rates are observed for the youngest age groups
(0-4, 5-18, and 19-44). Antibiotic consumption among individuals aged 65 or above
is by far the lowest in all the age groups, probably due to higher hospitalization rates.
Also, there is a signicant association between a higher prevalence of diseases, such
as diabetes mellitus, and higher antibiotic consumption. Conversely, higher rates
of hospitalization seem to be correlated with lower levels of antibiotic consumption.
Finally, the authors nd large variability between the districts in the use of specic
antibiotic groups. The use of penicillins in high consumption districts, for instance,
is 2.8 times the use in low consumption districts. The magnitude of di¤erences raises
to 3.9 in the use of rst-generation cephalosporines.
To investigate socioeconomic determinants of outpatient antibiotic use in Switzer-
land, Filippini et al. (2006) use regional consumption data and regress them against
a set of variables suggested by the literature as plausible causal factors of the demand
for drugs. The dataset includes quarterly data for 3 years (2002-2004) detailed at
cantonal level (26 cantons). Findings show that Switzerland uses relatively low vol-
umes of antibiotics in ambulatory care compared to other European countries, but
large di¤erences are observed across cantons. The authors specify an ad-hoc demand
function for the cantonal per capita outpatient antibiotic use which depends upon the
health status of individuals, income, antibiotic price, age, education, density of physi-
cians and cultural aspects summarised by linguistic groups and borders with other
countries. Since individuals health status and antibiotic price can be endogenous,
the authors consider the inclusion of lagged values in the model and apply an instru-
mental variable approach. The per capita income, antibiotic price, the proportion
of foreign residents, the density of medical practices, and cultural and educational
di¤erences are signicant determinants of consumption. Among these results, it is
worth noting that income has a positive impact on consumption, and antibiotic price
has a negative and signicant e¤ect, as expected. Conversely, physician density is
associated with higher levels of antibiotic use.
Kern et al. (2006) carry out an exploratory analysis on antibiotic prescriptions
in Germany for the year 2003. They investigate variations in outpatient antibiotics
between 23 areas in 16 states both for overall use and for the use of specic classes of
antibiotics. Relatively low antibiotic consumption is observed in eastern and southern
regions. Basic penicillins are the most frequently prescribed drugs with large regional
variation. Regional patterns of use are similar for children and adults, although lower
levels of consumption for children are observed in the south. The study does not nd
an association between overall antimicrobial consumption and population density,
the percentage of elderly people, income, unemployment, gross domestic product
and aspects of local health care supply, but the analysis lacks of a sound econometric
approach.
5
Filippini et al. (2009a) investigate ine¢ ciencies in the use of outpatient antibi-
otics across small areas. The authors carry out econometric estimations using a
two-stage least squares procedure on quarterly data of antibiotic use (in DID) in
Swiss outpatients available for 240 small areas in 2002. A model is proposed in
which antibiotic use varies according to the socioeconomic and demographic charac-
teristics of the population, the incidence of infections, the local supply of health care
and antibiotic price. The results suggest a positive relationship between antibiotic
consumption and income, the proportion of children between 0 and 14 years of age,
the percentage of foreigners in the total population, the incidence of infections, and
density of pharmacies and physicians. On the other hand, antibiotic price and the
proportion of individuals over 74 years of age show a negative and signicant impact
on antibiotic use. Some seasonal e¤ects are found, which suggest that the per capita
outpatient antibiotic use is lower in spring and summer periods. Finally, the authors
consider the e¤ects of spatial dependency in antibiotic consumption across the areas
by means of spatial lags included in their model. The negative impact of antibiotic
use in neighbouring areas suggests that the use of antibiotics in one area may reduce
the spread of infections in neighbouring areas.
Finally, Matuz et al. (2005) investigate regional variations in antibiotic con-
sumption in ambulatory care in Hungary. The sample is composed of 19 regions
(counties) for the years 1996-2003. The authors nd that antibiotic consumption
was 21.1 DID in 1998, close to the European average, but decreases from 2002. The
study shows large and stable interregional variations in consumption. The ranking of
regions according to total antimicrobial consumption is basically the same during the
whole period. The authors test associations between total antibiotic consumption
and possible determinants of use by means of the two-tailed Spearman coe¢ cient for
non-parametric correlations. They do not nd any signicant relationship between
antibiotic consumption and the average monthly net income nor with the demo-
graphic structure of the population. Conversely, a signicant association with total
antibiotic consumption is observed with the proportion of individuals receiving free
access to selected medicines from the public health system without quantity limit
and the proportion of individuals regularly receiving social assistance.
3 Outpatient antibiotic consumption within the Italian
NHS
The Italian health care system is based upon a national health service (SSN) mainly
nanced by general taxation and characterised by universal access to health care for
the entire population and asymmetric decentralization of health care provision to the
20 regions. Reforms over the 90s gave administrative and nancial responsibility in
the provision of health care to the regions. The central government retains limited
supervisory control and continues to hold overall responsibility for the SSN to assure
access and equal levels of health services across the country. The regions organise
services that are designed to meet the needs of their local populations, dene ways
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Figure 1: Outpatient antibiotic use in Europe by country (2000-2007). Data source:
European Surveillance of Antimicrobial Consumption (ESAC).
to allocate nancial resources to the local health authorities (LHAs) within their
territories, monitor health care services and activities provided by LHAs, and assess
their performance.
Outpatient care in Italy is provided by general practitioners (GPs), paediatricians
and specialists. General practitioners and paediatricians deliver primary care and
preventive medicine and are mainly paid on a capitation basis. Generally, patients
do not pay for visits to GPs. They also enjoy considerable freedom of choice of
providers since they are only obliged to use providers in the province in which they
reside and they must have a doctors prescription for most forms of care. Patients
can always change their GP within the province of residence (Atella et al., 2003).
Specialists delivering outpatient care are paid on a fee-for-service basis. Patients pay
only a small fraction of the full cost of a consultation if they are referred by their
GP.
Medicines in outpatient care are classied in two categories. The rst category
(class A) includes essential medicines and medicines for serious and chronic diseases
which require a doctors prescription. These drugs are fully reimbursed by the SSN,
although patients bear small copayments in some regions. Antibiotics are generally
included in this category and the copayment (ticket) includes both a cost-sharing
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Figure 2: Outpatient antibiotic use in Italy by region (2000-2008). Data source:
Italian National Observatory on Drugs Utilisation (OSMED).
scheme and a reference pricing one.2 According to this, patients are required to
contribute to the cost of antibiotics either by a xed amount per prescription or
by a proportional-to-nal price amount, or by paying the di¤erence between the
nal price and the reference price.3 Generally, people with chronic or rare diseases,
disabled people, pregnant women and low income people benet from exemptions.
The reference price is set for drugs that contain the same active ingredient, identical
pharmaceutical dosage and package size. The second category of drugs - the so-called
class C- includes medicines for minor diseases and ailments, medicines the use of
which is discouraged and those not requiring a medical prescription. Pharmaceutical
products included in this category are not reimbursed by the SSN.
As concerning the use of outpatient antibiotics, Italy is a relatively high-con-
suming country. Using available data from the European Surveillance of Antimi-
crobials Consumption (ESAC) between 2000 and 2007 we can rank Italy among
European countries according to the number of dened daily doses per 1000 inhab-
itants consumed (Figure 1). Italy ranks among the most consuming countries, just
2 In Italy only 1% of antibiotic courses are obtained from a pharmacy without a prescription.
3See Fiorio and Siciliani (2010) for details.
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below France, Greece, Luxemburg and Slovakia. In contrast, the Netherlands, Aus-
tria and Denmark are among the least consuming countries. A recent survey by the
European Commission (2010) indicates that Italy had the highest rate of antibiotic
use across Europe between December 2008 and November 2009. Moreover, the ma-
jority of the population (51%) thinks that antibiotics are e¤ective against common
infections, such as colds or u, which are not cured by antibiotics. This evidence
raises concern about the e¢ cient use of antibiotics in the country.
The mean level of consumption of outpatient antibiotics in Italy between 2000
and 2008 was 23.53 DID, with a peak in 2008 (25.01 DID) and a minimum in 2000
(22.36 DID).4 Figure 2 shows that antimicrobial use has been roughly stable over this
period but a remarkable degree of heterogeneity in consumption is observed across
the regions. Generally, regions in central Italy use more antibiotics per capita (24.94
DID) than regions in the north (18.43 DID) and less than southern regions and the
islands (28.74 DID).
The largest mean share of consumption during the time period considered is rep-
resented by the combinations of penicillin with beta-lactamase inhibitor (25.76%),
4Data are collected by the Italian agency for drugs (AIFA).
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followed by the macrolides (21.57%). Other categories of antimicrobials predomi-
nately used in the community are the broad-spectrum penicillins (20.59%) and the
quinolones (13.64%). The structure of consumption has slightly changed over the 8-
year period (Figure 3). The share of combination of penicillin increased from 18.88%
in 2000 to 31.10% in 2008. This increase was partially compensated by a decrease in
broad-spectrum penicillins, from 22.45% in 2000 to 17.20% in 2008. In this respect,
it is worth noting that changes in the use of antibiotic classes are associated to sub-
sequent changes in bacterial resistance. It has been observed that current penicillin
resistance depends on the cumulative consumption in the previous two years (Al-
bricht et al., 2004). The substitution of broad-spectrum penicillins with combination
of penicillin with beta-lactamase inhibitors is at least partially explained by the re-
duced e¤ectiveness of the former category due to increasing bacterial resistance and
the availability of a more dynamic subclass of penicillins (Ferech, et al., 2006).
4 Model specication and data
We propose a reduced-form consumption function for outpatient antibiotics,5 where
the variability in antibiotic use among Italian regions depends on socioeconomic
characteristics of the population (age structure and income), the supply of health
care, individuals health status, and the price (copayment) of antibiotics. Antibiotic
consumption in di¤erent periods is assumed to be fully separable (Bretteville-Jensen,
2006). This means that current consumption a¤ects consumers utility in the current
period only, without consumers preferences interactions across time periods.
The following model is specied:
DIDit = f(Yit; Pit; DPHit; POP1it; POP2it; INFit), (1)
where the subscript i denotes the region and t the time period. DIDit is antibiotic
consumption per capita; POP1it is the proportion of the population below 25 years
and POP2it indicates the proportion of the population older than 64. DPHit is the
density of general practices and INFit is the mortality rate from infectious diseases,
which is a proxy for individuals health status. Finally, the model includes income
(Yit) and copayment for pharmaceuticals (Pit).6
For the estimation of equation (1) we use a hybrid log-log functional form.7
The log transformation is applied to income and copayment only since the other
5Within the Italian NHS, outpatient antibiotic consumption originates from prescriptions by
general practitioners. We hypothesize that the demand for antibiotics for patients registered in the
GPs list is dened by the representative general practitioner in the region by taking patientsneeds
and preferences into account.
6There is evidence that income is strongly associated with education and is preferred as a deter-
minant of inequalities in the use of health care services (Habitch et al., 2009).
7A linear functional form has also been considered. In this case, the results are less satisfactory
in terms of goodness of t and the signicance of the coe¢ cients.
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covariates are dened as percentage ratios. Equation (1) can then be written as:
lnDIDit = 0 + 1 lnYit + 2 lnPit + 3DPHit + 4POP1it (2)
+5POP2it + 6INFit + it.
Coe¢ cients 4 and 5 capture the e¤ect of the young and the old population,
respectively, as compared to the reference population group aged between 25 and 65.
it is an error component with standard normality assumptions.
Our dataset is a balanced panel which includes data for 9 years, from 2000 to 2008,
for 20 Italian regions. Summary statistics are reported in Table 2. Data on regional
outpatient antibiotic consumption are collected from annual reports prepared by
the Italian National Observatory on Drugs Utilization (Osmed). The per capita
consumption is measured by the number of dened daily doses (DDD) per 1000
inhabitants per day (DID). A DDD represents the standard dose necessary for one
day of drug treatment in adults and is dened by an independent scientic committee
answering to the WHO Collaborating Center for Drug Statistics Methodology. The
DID measure can be interpreted as the number of persons (out of 1000) who are
taking antibiotics on a given day (Monnet et al., 2004). The dataset comprises sales
of antimicrobial drugs - group J of the Anatomical Therapeutic Chemical (ATC)
classication - included in class A by the Italian NHS (see Section 3 above). These
drugs require a doctors prescription and are supplied virtually free of charge, against
small patient copayments.
Information on the demographic structure of the population, per capita income,
density of general practices and mortality from infectious diseases are obtained from
the Italian National Institute of Statistics (Istat). Copayments are obtained from
annual reports on pharmaceutical consumption and expenditure prepared by Osmed.
Regional copayments vary from 0 to 4 Euros. We rescale the variable from 1 to 5
in order to avoid negative values in the log transformation.8 Mortality data for
infectious diseases in 2004 and 2005 are not available. Since data are substantially
stable before and after this period, we linearly interpolate mortality data from 2003
and 2006 to assign values to the years 2004 and 2005. We are aware that this
approximation could create some bias in the estimation. We then carefully discuss
the estimation results related to this covariate in Section 6.
5 Econometric approach
Two main aspects have to be addressed for a correct approach to the estimation of
equation (2): the panel structure of the data and the presence of spatial correlation
of antibiotic consumption across regions. As suggested by Baltagi (2005), the use of
panel data has some advantages compared to the use of pure time series or cross-
sectional data. Panel data allow to control for individual heterogeneity and are more
8Adding a positive scalar (k) to the values of a covariate (X) ensures that the function log(X+k)
is always dened. See Gujarati (1995) for details.
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Variable Description Mean Std. error Min. Max.
DID Dened daily doses per 1,000 pop. 23.53 5.16 14.52 33.62
Y Income per capita (in Euro) 23,070 5,848 12,922 34,149
P Copayment (in Euro) 0.84 0.95 0 4
POP1 Proportion of population aged 0-24 24.46 3.59 18.45 33.59
POP2 Proportion of pop. aged above 64 20.01 2.78 13.86 26.79
DPH Density of physicians per 1,000 pop. 0.82 0.06 0.63 0.94
INF Mortality rate for infectious diseases 0.99 0.34 0.25 1.81
per 100,000 pop.
Table 2: Descriptive statistics of variables (years 2000-2008).
informative. Furthermore, they present more variability and less collinearity, and
provide more degrees of freedom and more e¢ cient estimates. Finally, they o¤er the
advantage that units are observed through time and this allows for a simplication
of economic aspects that, otherwise, would be more di¢ cult to study. The temporal
dimension pertains to periodic observations of variables characterising cross-sectional
units over time. Consequently, two sources of variation are identied: the variation
within units over time (within variation) and the variation across units (between vari-
ation). These two sources of variation are di¤erently considered by the most widely
used econometric approaches to panel data: the pooled ordinary least-squares (OLS)
model, the xed-e¤ects (FE) model and the random-e¤ects (RE) model. Conversely,
the spatial aspect pertains to the analysis of the e¤ects of the dependent variable
between units (regions). This aspect will be taken into account by means of adequate
spatial econometrics estimators included in the above models.
We estimate a FE model, which is a linear regression approach where the intercept
term varies cross-sectionally (over the individual units and/or over time). Thus,
the common formulation of the model assumes that di¤erences across units can be
captured by di¤erences in intercept terms. To test the hypothesis of homogeneity
in the constant terms across regions and time periods, we previously run an F -test.
The large F -test statistics suggests that a panel data approach via the FE estimator
would give more e¢ cient estimates compared to the pooled OLS approach.
An alternative to the FE approach is the RE model, where the individual term
is a stochastic factor, independently and identically distributed across units. The
Lagrange multiplier test (Breusch and Pagan, 1979) also indicates that the OLS
model can be rejected in favour of the RE model. Moreover, using the Hausman test
we verify the hypothesis that the individual-specic error terms are uncorrelated
with the explanatory variables, i.e. the RE estimator may be inconsistent. Since the
Hausman-test statistics is signicant at less than 5% level, we decide to focus on the
consistent xed-e¤ects estimator (see Cameron and Trivedi, 2005, for more details).
Note also the relevance of the within variation in most of our covariates.
Concerning the spatial aspect, it is worth noting that regional antibiotic consump-
tion can be a¤ected by individualsand physiciansattitudes towards antibiotics in
adjacent regions. This externality problem can be taken into account by means of
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adequate spatial econometrics estimators. There are two notable ways to introduce
spatial autocorrelation in regression models. These are the spatial-lag model and the
spatial-error model. The former refers to a situation where antibiotic consumption
in one region is a¤ected by antibiotic consumption in nearby regions. The spatial-lag
model is appropriate when there are spillover e¤ects from neighbouring regions. The
latter model of spatial dependence focuses on the error term and assumes that error
terms in di¤erent regions are correlated. This kind of spatial dependence occurs if
there are variables that are omitted from the regression model but do have an e¤ect
on the dependent variable and are spatially correlated. It is the case, for instance,
of random shocks spreading to neighbouring regions.
Both approaches requires the preliminary specication of a matrix of spatial
weights (W ). This matrix contains information on the spatial association between
observational units. We construct a contiguity matrix indicating which regions share
a border.9 According to this proximity criterion, the elements of the spatial weight
matrix are 1 if location i is adjacent to location j, and zero otherwise. The stan-
dardized matrix of spatial weights can then be used to test the presence of spatial
autocorrelation.
We run two tests of spatial autocorrelation: the Morans I (Moran, 1948; Cli¤
and Ord, 1973; 1981) and Gearys C statistics (Geary, 1954). Morans I statistic is
a weighted correlation coe¢ cient formulated as a normalized quadratic form of the
variables tested for spatial correlation. Variables are standardised by subtracting
the sample mean and then deated by the variance of the data (Anselin and Bera,
1998). Values range from -1 to +1, where +1 indicates perfect positive correlation,
0 implies no spatial correlation (provided the number of observations is large), and
-1 indicates perfect negative correlation. Morans I values can then be transformed
to Z-scores for statistical hypothesis testing. The Gearys C statistics gives a value
between 0 and 2. The lower value indicates a strong positive spatial autocorrelation.
A value of 1 suggests that no spatial autocorrelation is present, whereas negative
spatial association is suggested by a value greater than 1 (Goodchild, 1987). This
test is inversely related to Morans I but is more sensitive to local rather than global
spatial autocorrelation.
The spatial-lag model can be dened as:
DID = WDID +X + ", (3)
where DID is an Nx1 vector of observations on antibiotic consumption per capita,
with N = 160;WDID is the spatial lag of antibiotic consumption and  is the spatial
autoregressive parameter; X is the Nxk matrix of explanatory variables, with k = 6;
 is the vector of regression parameters and " is a vector of errors.
It is worth noting that spatial dependency is similar to having a lagged-dependent
variable as an explanatory variable. The spatial-lag model represents a suitable ap-
proach to the study of spatial autocorrelation in antimicrobial consumption since it
9 In the case of Sardinia and Sicily the weights were assigned on the basis of the network of
maritime routes which links the two islands to the peninsula.
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assumes that antibiotic use is characterised by consumption externalities as suggested
by the literature (Fingleton, 2003; Cabrer-Borrás and Serrano-Domingo, 2007). In-
deed, antibiotics have a preventive e¤ect since their use may provide external benets
to other individuals, and consequently, reduce the need for consumption in neigh-
bouring areas. However, antibiotics may also produce negative externalities since
their utilization may reduce antibiotic e¤ectiveness (increasing bacterial resistance)
which may spread to other areas.
As an alternative to the spatial-lag model, we apply the spatial-error model. This
is more relevant than the spatial-lag approach when the distribution of residuals in
di¤erent regions displays spatial correlation. Residuals may be spatially correlated
if aggregated shocks hit regional health authorities or there are unobservable risk
factors concentrated across the areas (Moscone and Knapp, 2005). This e¤ect may
be due, for instance, to exogenous bacterial resistance breakdown spreading across
the country.
The spatial-error model can be dened as:
DID = X + " (4)
" = W"+ , (5)
where  is the spatial-autoregressive coe¢ cient and  is a vector of errors that are
assumed to be independently and identically distributed. Note from equation (5)
that errors depend on the weighted average of errors in neighbouring regions.
Both spatial approaches have to deal with estimation bias. The multidirectional
nature of spatial dependence in the spatial-error model implies that generalized least-
squares estimators are inconsistent. The spatial-lag model exhibits endogeneity that
can be taken into account by instrumental variables or the general methods of mo-
ments techniques, but should preferably be solved using an appropriate maximum
likelihood estimator (see Anselin 1988, for details).
In the context of panel data, xed e¤ects can be included in the estimation of
equation (3), which leads to a xed-e¤ects spatial-lag model (SLFE). A maximum
likelihood (ML) procedure can be used to estimate the model.10 Similarly, one can
estimate a xed-e¤ects spatial error-model (SEFE) (see e.g. Elhorst, 2003) using
equation (4) and (5). In both models, we use the lagged mortality rate instead of
the mortality rate to tackle possible endogeneity related to the health status of the
population. Our estimations are carried out using the statistical software STATA
(version 11).
6 Results
Preliminary OLS regressions show an R2 adjusted of 0:77 (0:80 with a time trend
or temporal dummy variables). The F test is 91:91 (92:53 and 49:28 with a time
10The procedure developed by Pisati (2001) to investigate spatially correlated cross-sectional data
using maximum likelihood can be easily adapted to estimate a xed-e¤ects spatial-lag model.
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Test Statistics p-value
Morans I 0.797 0.000
Gearys C 0.167 0.000
LM (lag) 22.790 0.000
Robust LM (lag) 57.049 0.000
LM (error) 1.215 0.270
Robust LM (error) 35.473 0.000
Table 3: Results of tests for spatial dependency.
trend and time dummies, respecitvely). This suggests that overall regressors have a
signicant impact on the dependent variable. Moreover, the mean Variance Ination
Factor is lower than 5. Finally, the Shapiro-Wilk test as well as the Jarque-Bera
test for normality of errors cannot be rejected using the conventional 95% level of
signicance.
Our initial tests also indicate that the OLS model can be rejected in favour of the
FE and the RE models. The Breusch and Pagan lagrangian multiplier test indicates
that there are e¤ects other than those captured by the exogenous variables in OLS
regressions. The F test that constant terms are homogeneous across regions and time
periods is also rejected. Moreover, the Hausman test suggests that the FE approach
should be preferred to the RE approach. The Hausman test has a value of 74:44 and
a p-value of 0:00. Consequently, the estimation results reported in Table 4 focus on
the FE model.
To account for possible cross-sectional dependence, we also estimated a FE model
using the Driscoll-Kraay correction to standard errors (Driscoll and Kraay, 1998).
Ignoring cross-sectional correlation in the estimation of panel models can lead to
severely biased statistical results. The statistical signicance of the coe¢ cients in our
regression slighly improves when the Driscoll-Kraay correction is applied. Finally, to
check the robustness of our results and address possible endogeneity of population
health status we run separate regressions using the lag of mortality for infections
and an instrumental variable approach using population density as instrument for
infections. The main results are unchanged.
Generally, only a few coe¢ cients are signicant. Nevertheless, the goodness of t
of our preliminary estimation with OLS is not far from the results of previous analysis
of antimicrobial use at regional level. Because we use a log-log functional form, we can
interpret coe¢ cients for income and price as elasticities. In the FE estimation, income
elasticity is positive and highly signicant. The result suggests that regions with
higher levels of income, i.e. northern Italian regions, use more antibiotics compared
to lower income regions, ceteris paribus. Generally, a 1% increase in income increases
antibiotic consumption by 0:64%. Positive income e¤ects for antimicrobials are also
observed by Baye et al. (1997) using US data, and by Filippini et al. (2009a) using
Swiss data. According to the authors, one possible explanation for this low elasticity
value is that the increasing concern over the e¤ects of bacterial resistance from the
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1990s may have reduced income elasticity of outpatient antibiotic expenditure over
time. Another explanation is that individuals with higher income are more likely to
substitute away antibiotics for alternative treatments when income increases.
As expected, copayment has a negative and signicant impact on consumption
( 0:015). Many studies suggest that copayments are e¤ective in reducing drug con-
sumption at individual level (Freemantle and Bloor, 1996). Using data from Italy,
Fiorio and Siciliani (2009) investigate the e¤ect of copayments on the demand for
pharmaceuticals. They nd that an increase in copayments by e1 reduces the per
capita number of prescriptions by 4% and the per capita public pharmaceutical ex-
penditures by 3:4%. Therefore, the e¤ect of a variation in the level of copayment
is not negligible. Our estimates are lower than those found by Contoyannis et al.
(2005), who investigate exogenous changes in the cost-sharing of prescription drugs
in Canada (between  0:12 and  0:16). Own-price elasticities calculated by Rudholm
(2003) for three Swedish pharmaceutical submarkets between 1989 and 1996 are also
lower (between  0:12 and  3:43).
Finally, we observe that the coe¢ cient of mortality rate for infectious diseases
( 0:01) is not signicant. This suggests that improvements in population health
status are not signicantly associated to increasing rates of antibiotic use.
The results of the two spatial models with xed e¤ects (SLFE and SEFE) are
also reported in Table 4. For comparison purposes we run spatial random-e¤ects
estimations with maximum likelihood and observed that the sign and the signicance
of all the coe¢ cients do not di¤er substantially from estimations with xed e¤ects.
Table 3 summarises the results of two tests for spatial dependence: the Morans I
test and the Gearys C test. In both cases, the null hypothesis is rejected, which
suggests evidence of spatial autocorrelation in antibiotic use among Italian regions.
It is then advisable to extend our FE model to include interdependence of antibiotic
consumption across regions by means of spatial models. In order to identify the
appropriate form of spatial autocorrelation, we use two Lagrange multiplier (LM)
tests and their robust versions. The LM test for a spatial lag and the LM test for
spatially autoregressive errors both suggest the presence of spatial dependency (Table
3). The LM test statistics for the spatially lagged dependent variable are always
signicant at the 0:1% level. Regarding the model with spatially autoregressive
errors, only the robust LM test statistic is signicant at the 0:1% level. This leads
us to conclude that there is no clear evidence in favour of one specication approach
over the other. Estimation results for both spatial specication approaches are then
discussed and reported in Table 4.
We estimate the spatial-lag model and the spatial-error model taking unobserv-
able e¤ects into account by means of regional dummies. The maximul likelihood
procedure for spatial analysis of cross-sectional data developed by Pisati (2001) has
been adapted to take xed e¤ects into account. Estimations with a time trend and
time dummies have also been considered. Our results are robust to the inclusion
of a time trend. The inclusion of temporal dummies reduces the signicance of the
spatial e¤ects but the result is undermined by the large number of dummy variables
(regional e¤ects and temporal e¤ects) and the small number of observations.
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The estimates of the two spatial models are quite similar. Region dummies are
all highly signicant with a couple of exceptions. Income is highly signicant in both
models. Antibiotic copayment is signicant at less than 5%. The proportion of people
aged above 64 is also signicant at less than 1% in the spatial-lag model and less than
5% in the spatial-error model. This suggests that elderly individuals are less likely
to use outpatients antibiotics compared to younger individuals. According to the
literature there is a U -shaped relationship between health care spending and age (Di
Matteo, 2005). Young and elderly individuals generally use more health services than
the mid-age population. In the case of outpatient antibiotics the relationship seems
to be reinversed maybe because individuals in the labor force have higher opportunity
cost of time and tend to shorten time to recover by means of drug therapy.
As for the spatial coe¢ cients, these are signicant in the spatial-lag and the
spatial-error models at 5% and 1% level respectively. One could argue that one
of these two models captures the dynamics of the externalities involved (bacterial
resistance and prevention from infections) better than the other. This would imply
that the spillover process is either deterministic or similar to a random shock. One
result of our analysis is that the spatial-lag parameter in the spatial-lag model () is
less signicant than the spatial autocorrelation coe¢ cient in the spatial-error model
(). This may suggest that random shocks related to the dynamics of infections may
better explain spatial interactions between neighbouring areas in the consumption of
antibiotics.
7 Conclusions
Most of the empirical evidence on socioeconomic determinants of antibiotic consump-
tion is based on cross-sectional data and limited to few countries (e.g. Switzerland,
Germany, Israel and Hungary). In particular, evidence lacks from countries with a
National Health Service and substantial decentralization of health care provision to
regional health authorities. The cross-sectional approach has some drawbacks such
as the inability to solve the problem of omitted variables. This is even more relevant
when only limited data are available for important factors, such as bacterial resis-
tance to antimicrobials. A further limitation is represented by the need to impose full
regional homogeneity in the parameters of the random process that describes the use
of antibiotics. To overcome these problems, we analysed socioeconomic determinants
of antibiotic consumption by means of panel data from a new country (Italy).
The consumption of antibiotics cannot be regarded as independently generated
within regions because of possible spillover e¤ects. Antibiotics may reduce the risk of
infections in neighbouring areas (positive externality) and may reduce the e¤ective-
ness of treatment because of bacterial resistance spreading (negative externality). As
a consequence, standard estimation procedures employed in many empirical studies
can lead to bias and ine¢ ciency in the estimates. Our approach allowed to consider
spatial e¤ects across regions. We captured these e¤ects by means of a spatial-lag
model and a spatial-error model.
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We found some evidence of spatial autocorrelation in the use of antibiotics across
Italian regions. This suggests that regional policies (e.g. public campaigns) aimed
at increasing e¢ ciency in antibiotic consumption and controlling bacterial resistance
may not be independent and could be inuenced by policy makers in neighbouring
regions. There will be scope for a strategic and coordinated view of regional policies
towards the use of antibiotics.
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